Copy Link Print Information

Certolizumab pegol

(Synonyms: Certolizumab; CDP870)
2 Cited Publications
Revisión del cliente

Based on 2 publication(s) in Google Scholar

Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycosylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.00%
  • No. CAS: 428863-50-7
  • Peso molecular:91 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Certolizumab pegol
  • Experimental Validation Results for Certolizumab pegol
  • Experimental Validation Results for Certolizumab pegol
  • Certolizumab pegol Chemical Structure
    Certolizumab pegol Chemical Structure
No. CAS: 428863-50-7
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Certolizumab pegol Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Certolizumab pegol

More

Ver todos los productos específicos de isoformas TNF Receptor

More

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Fab'-G1-kappa

  • 1/16

    Immobilized TNF-alpha/TNFSF2 Protein, Human (HY-P7058) can bind Certolizumab pegol. The EC50 for this effect is 238 ng/mL.

  • 1/16

    Flow cytometric analysis of 1.5X106 RAW264.7 cells treated with 1µg/mL LPS for 24h with Certolizumab pegol (HY-P9953, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Certolizumab pegol Chemical Structure
    1/16
  • Certolizumab pegol
  • Immobilized TNF-alpha/TNFSF2 Protein, Human (HY-P7058) can bind Certolizumab pegol. The EC50 for this effect is 238 ng/mL.
  • Flow cytometric analysis of 1.5X106 RAW264.7 cells treated with 1µg/mL LPS for 24h with Certolizumab pegol (HY-P9953, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Fab'-G1-kappa